124 related articles for article (PubMed ID: 38241682)
21. Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.
Bellomo J; Zeitlberger AM; Padevit L; Stumpo V; Gönel M; Fierstra J; Nierobisch N; Reimann R; Witzel I; Weller M; Le Rhun E; Bozinov O; Regli L; Neidert MC; Serra C; Voglis S
J Neurooncol; 2024 Jun; ():. PubMed ID: 38829577
[TBL] [Abstract][Full Text] [Related]
22. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.
Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L
Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785
[TBL] [Abstract][Full Text] [Related]
23. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
25. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
Yu X; Sheng J; Pan G; Fan Y
Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
27. Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity-Matched Analysis of Surveillance, Epidemiology, and End Results Database.
Wang Q; Li J; Liang X; Zhan Q
Front Oncol; 2022; 12():888999. PubMed ID: 35936705
[TBL] [Abstract][Full Text] [Related]
28. Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study.
Fuchs J; Früh M; Papachristofilou A; Bubendorf L; Häuptle P; Jost L; Zippelius A; Rothschild SI
PLoS One; 2021; 16(6):e0253601. PubMed ID: 34181677
[TBL] [Abstract][Full Text] [Related]
29. Recurrent brain metastases: the role of resection of in a comprehensive multidisciplinary treatment setting.
Heßler N; Jünger ST; Meissner AK; Kocher M; Goldbrunner R; Grau S
BMC Cancer; 2022 Mar; 22(1):275. PubMed ID: 35291972
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of metabolic parameters derived from preoperative
Shang J; Tang Y; Ran B; Wu B; Li Y; Cheng Y; Guo B; Gong J; Wang L; Ling X; Xu H
Quant Imaging Med Surg; 2023 Dec; 13(12):8545-8556. PubMed ID: 38106281
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study.
Zhong Q; Liu Z
Cancer Manag Res; 2021; 13():4115-4128. PubMed ID: 34045898
[TBL] [Abstract][Full Text] [Related]
33. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
[TBL] [Abstract][Full Text] [Related]
34. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
Balasubramanian SK; Sharma M; Venur VA; Schmitt P; Kotecha R; Chao ST; Suh JH; Angelov L; Mohammadi AM; Vogelbaum MA; Barnett GH; Jia X; Pennell NA; Ahluwalia MS
Neuro Oncol; 2020 Feb; 22(2):267-277. PubMed ID: 31648302
[TBL] [Abstract][Full Text] [Related]
35. Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan.
Yoshida H; Kim YH; Iwatsubo S; Sakaguchi C; Sakamori Y; Nagai H; Ozasa H; Mio T; Hirai T
Oncology; 2020; 98(7):460-467. PubMed ID: 32222702
[TBL] [Abstract][Full Text] [Related]
36. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
37. Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer.
Xu YB; Zhang Y; Song Z; Wang W; Shao L
Cancer Manag Res; 2021; 13():6309-6317. PubMed ID: 34408492
[TBL] [Abstract][Full Text] [Related]
38. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.
Likhacheva A; Pinnix CC; Parikh NR; Allen PK; McAleer MF; Chiu MS; Sulman EP; Mahajan A; Guha-Thakurta N; Prabhu SS; Cahill DP; Luo D; Shiu AS; Brown PD; Chang EL
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):656-61. PubMed ID: 22898384
[TBL] [Abstract][Full Text] [Related]
39. Real-world analysis of first-line afatinib in patients with
Kim J; Jang TW; Choi CM; Kim MH; Lee SY; Park CK; Chang YS; Lee KY; Kim SJ; Yang SH; Ryu JS; Lee JE; Lee SY; Park CK; Lee SH; Jang SH; Yoon SH
Transl Lung Cancer Res; 2023 Jun; 12(6):1197-1209. PubMed ID: 37425421
[TBL] [Abstract][Full Text] [Related]
40. Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study.
Hao Y; Tang T; Ren J; Li G
Radiol Med; 2023 Oct; 128(10):1271-1283. PubMed ID: 37648956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]